Cellectar Biosciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.20

+0.26 (+8.84%)

As of May 16, 2:29 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target +1,190.0% upside

Low Target $32.58

Average Target $41.28

High Target $58.47

Current Price $3.20

Current
$3.20

Target
$41.28

$32.58 $41.28 avg $58.47

Scenario Analysis

Bear Case

$32.58

918.1%

Low target

Base Case

$41.28

+1,190.0%

Avg target

Bull Case

$58.47

+1,727.2%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$20.70

-84.5% from high

52-Week Low

$2.43

+31.7% from low

Target vs 52W High

$41.28

+99.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%